Form 8-K - Current report:
SEC Accession No. 0001193125-24-067483
Filing Date
2024-03-14
Accepted
2024-03-14 09:35:01
Documents
15
Period of Report
2024-03-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d792547d8k.htm   iXBRL 8-K 27374
2 EX-99.1 d792547dex991.htm EX-99.1 3813
  Complete submission text file 0001193125-24-067483.txt   156439

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bttx-20240314.xsd EX-101.SCH 2892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20240314_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20240314_pre.xml EX-101.PRE 11286
17 EXTRACTED XBRL INSTANCE DOCUMENT d792547d8k_htm.xml XML 3651
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 24748155
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)